Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia.

Allan, J M; Sunter, N J; Bailey, J R; Pettitt, A R; Harris, R J; Pepper, C; Fegan, C; Hall, A G; Deignan, L; Bacon, C M; Pointon, J C; Houlston, R S; Broderick, P; Mainou-Fowler, T; Jackson, G H; Summerfield, G; Evans, P A; Strefford, J C; Parker, A; Oscier, D; Pratt, G; Allsup, D J

Allan, J M; Sunter, N J; Bailey, J R; Pettitt, A R; Harris, R J; Pepper, C; Fegan, C; Hall, A G; Deignan, L; Bacon, C M; Pointon, J C; Houlston, R S; Broderick, P; Mainou-Fowler, T; Jackson, G H; Summerfield, G; Evans, P A; Strefford, J C; Parker, A; Oscier, D; Pratt, G; Allsup, D J.

Leukemia ; 24(4): 877-81, 2010 Apr.

Article in En | MEDLINE | ID: mdl-20090783

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Variation / Leukemia, Lymphocytic, Chronic, B-Cell / ADP-ribosyl Cyclase 1 / Interferon Regulatory Factors Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2010 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google